Concepedia

Richard Forth

RF

Statistics

Publications

11

Citations

499

H-Index

11

Active since

2010

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

University of Cape Town

University of Manchester

University of Wisconsin–Madison

University of Gothenburg

Richard Forth is an author at GlaxoSmithKline (United Kingdom) specializing in asthma pharmacotherapy, pharmacy, and asthma management.

ORCID

Publications per year

2010–2017

11

Publications

11

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma

Paul M. O’Byrne, Eugene R. Bleecker, Eric D. Bateman et al. · European Respiratory Journal · 2013 · 86 citations · Full text

, , +17

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial

William W. Busse, Eugene R. Bleecker, Eric D. Bateman et al. · Thorax · 2011 · 75 citations

, , +17

Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial

Eric D. Bateman, Eugene R. Bleecker, Jan Lötvall et al. · Respiratory Medicine · 2012 · 67 citations · Full text

, , +7

Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma

David I. Bernstein, Eric D. Bateman, Ashley Woodcock et al. · Journal of Asthma · 2015 · 48 citations · Full text

, , +17

Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial

Eugene R. Bleecker, Jan Lötvall, Paul M. O’Byrne et al. · The Journal of Allergy and Clinical Immunology In Practice · 2014 · 48 citations

, , +7

1–5 of 11